24577472|t|Increased susceptibility to amyloid-beta-induced neurotoxicity in mice lacking the low-density lipoprotein receptor.
24577472|a|Familial hypercholesterolemia is caused by inherited genetic abnormalities that directly or indirectly affect the function of the low-density lipoprotein (LDL) receptor. This condition is characterized by defective catabolism of LDL which results in increased plasma cholesterol concentrations and premature coronary artery disease. Nevertheless, there is increasing preclinical and clinical evidence indicating that familial hypercholesterolemia subjects show a particularly high incidence of mild cognitive impairment. Moreover, the LDL receptor (LDLr) has been implicated as the main central nervous system apolipoprotein E receptor that regulates amyloid deposition in distinct mouse models of beta-amyloidosis. In this regard, herein we hypothesized that the lack of LDLr would enhance the susceptibility to amyloid-beta-(Abeta)-induced neurotoxicity in mice. Using the acute intracerebroventricular injection of aggregated Abeta(1-40) peptide (400 pmol/mouse), a useful approach for the investigation of molecular mechanisms involved in Abeta toxicity, we observed oxidative stress, neuroinflammation, and neuronal membrane damage within the hippocampus of C57BL/6 wild-type mice, which were associated with spatial reference memory and working memory impairments. In addition, our data show that LDLr knockout (LDLr(-/-)) mice, regardless of Abeta treatment, displayed memory deficits and increased blood-brain barrier permeability. Nonetheless, LDLr(-/-) mice treated with Abeta(1-40) peptide presented increased acetylcholinesterase activity, astrogliosis, oxidative imbalance, and cell permeability within the hippocampus in comparison with Abeta(1-40)-treated C57BL/6 wild-type mice. Overall, the present study shows that the lack of LDLr increases the susceptibility to Abeta-induced neurotoxicity in mice providing new evidence about the crosslink between familial hypercholesterolemia and cognitive impairment.
24577472	49	62	neurotoxicity	Disease	MESH:D020258
24577472	66	70	mice	Species	10090
24577472	83	115	low-density lipoprotein receptor	Gene	16835
24577472	117	146	Familial hypercholesterolemia	Disease	MESH:D006938
24577472	170	191	genetic abnormalities	Disease	MESH:D030342
24577472	247	285	low-density lipoprotein (LDL) receptor	Gene	16835
24577472	384	395	cholesterol	Chemical	MESH:D002784
24577472	425	448	coronary artery disease	Disease	MESH:D003324
24577472	534	563	familial hypercholesterolemia	Disease	MESH:D006938
24577472	616	636	cognitive impairment	Disease	MESH:D003072
24577472	652	664	LDL receptor	Gene	16835
24577472	666	670	LDLr	Gene	16835
24577472	768	786	amyloid deposition	Disease	MESH:D058225
24577472	799	804	mouse	Species	10090
24577472	815	831	beta-amyloidosis	Disease	MESH:D000686
24577472	889	893	LDLr	Gene	16835
24577472	959	972	neurotoxicity	Disease	MESH:D020258
24577472	976	980	mice	Species	10090
24577472	1046	1065	Abeta(1-40) peptide	Chemical	-
24577472	1076	1081	mouse	Species	10090
24577472	1166	1174	toxicity	Disease	MESH:D064420
24577472	1206	1223	neuroinflammation	Disease	MESH:D000090862
24577472	1229	1253	neuronal membrane damage	Disease	MESH:D015433
24577472	1280	1287	C57BL/6	CellLine	CVCL:C0MU
24577472	1298	1302	mice	Species	10090
24577472	1339	1386	reference memory and working memory impairments	Disease	MESH:D008569
24577472	1420	1424	LDLr	Gene	16835
24577472	1435	1439	LDLr	Gene	16835
24577472	1446	1450	mice	Species	10090
24577472	1493	1508	memory deficits	Disease	MESH:D008569
24577472	1570	1574	LDLr	Gene	16835
24577472	1580	1584	mice	Species	10090
24577472	1598	1617	Abeta(1-40) peptide	Chemical	-
24577472	1638	1658	acetylcholinesterase	Gene	11423
24577472	1669	1681	astrogliosis	Disease	MESH:D005911
24577472	1788	1795	C57BL/6	CellLine	CVCL:C0MU
24577472	1806	1810	mice	Species	10090
24577472	1862	1866	LDLr	Gene	16835
24577472	1913	1926	neurotoxicity	Disease	MESH:D020258
24577472	1930	1934	mice	Species	10090
24577472	1986	2015	familial hypercholesterolemia	Disease	MESH:D006938
24577472	2020	2040	cognitive impairment	Disease	MESH:D003072
24577472	Association	MESH:D020258	16835
24577472	Association	MESH:D005911	16835
24577472	Association	MESH:D006938	16835
24577472	Association	MESH:D003072	16835
24577472	Association	11423	16835
24577472	Association	MESH:D008569	16835
24577472	Association	MESH:D058225	16835
24577472	Association	MESH:D000686	16835
24577472	Association	MESH:D030342	16835

